TM
ANRO icon

Torren Management’s Alto Neuroscience ANRO Stock Holding History

Torren Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
558
– – 0.01% 171
2026
Q1 		$12.5K Sell
558
-2,926
-84% -$54.2K 0.01% 170
2025
Q4 		$62K Buy
+3,484
New +$43.9K 0.03% 264

Other funds holding ANRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return

Torren Management's ANRO Position: Q2 2026 in Review

Torren Management held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 558 shares worth $14.7K. The position accounts for 0.01% of the portfolio, ranked #171.

Torren Management first reported a position in ANRO in Q4 2025 and has held it in 3 quarters since. The position peaked at $62K in Q4 2025. 26 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Torren Management held 558 shares of Alto Neuroscience worth $14.7K as of Q2 2026.
  • Torren Management left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up 0.01% of Torren Management's portfolio in Q2 2026, its #171 holding.
  • Torren Management first reported a position in Alto Neuroscience in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Alto Neuroscience position peaked at $62K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.